Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

338

Participants

Timeline

Start Date

July 2, 2012

Primary Completion Date

October 15, 2014

Study Completion Date

May 13, 2015

Conditions
Knee Osteoarthritis
Interventions
DRUG

Enteron tab. 150mg(vitis vinifera extract 150mg) : twice daily for 12 weeks

"1. morning : 1 tab. of active Entelon 150mg plus 1 cap. of placebo Celebrex~2. evening : 1 tab. of active Entelon 150mg"

DRUG

Celebrex cap. (celecoxib 200mg) : once daily, for 12 weeks

"1. morning : 1 tab. of placebo Entelon 150mg + 1 cap. of active Celebrex~2. evening : 1 tab. of placebo Entelon 150mg"

DRUG

Placebo

"1. morning : 1 tab. of placebo Entelon 150mg + 1 cap. of placebo Celebrex~2. evening : 1 tab. of placebo Entelon 150mg"

Trial Locations (1)

420-717

The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT01768520 - Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee | Biotech Hunter | Biotech Hunter